Opinion|Videos|August 19, 2024
Key Takeaways on Enhancing Outcomes for mNSCLC Without Targetable Driver Mutations
The panel provides insights on enhancing outcomes for patients with metastatic non-small cell lung cancer without targetable driver mutations.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Looking ahead, what is the most critical priority to meaningfully enhance outcomes for patients with metastatic non-small cell lung cancer without targetable driver mutations?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Jeff Hunnicutt to Bring Community Oncology Roots to New Role as Navista COO
2
New MINT Trial Analysis Favors Liberal Transfusion After MI
3
Contributor: State Leaders Need Real-World Evidence to Integrate Social Care at Scale
4
Isatuximab OBI Cuts Infusion Reactions: Xavier Leleu, MD, PhD
5